Stiripentol (Diacomit®) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy

All Wales Medicines Strategy Group (AWMSG)
Record ID 32012000427
Authors' recommendations: Stiripentol (Diacomit®) is not recommended for use within NHS Wales for the treatment of severe myoclonic epilepsy in infancy
Project Status: Completed
Year Published: 2008
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Wales, United Kingdom
MeSH Terms
  • Child
  • Epilepsies, Myoclonic
  • Adolescent
  • Dioxolanes
  • Anticonvulsants
  • Benzodiazepines
  • Valproic Acid
Organisation Name: All Wales Medicines Strategy Group
Contact Address: All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX
Contact Name:
Contact Email:
Copyright: AWTTC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.